Literature DB >> 17256150

Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Justin P Rubio1, Melanie Bahlo, Jim Stankovich, Rachel K Burfoot, Laura J Johnson, Stewart Huxtable, Helmut Butzkueven, Ling Lin, Bruce V Taylor, Terence P Speed, Trevor J Kilpatrick, Emmanuel Mignot, Simon J Foote.   

Abstract

Human leucocyte antigen (HLA)-DRB1*15 is associated with predisposition to multiple sclerosis (MS), although conjecture surrounds the possible involvement of an alternate risk locus in the class I region of the HLA complex. We have shown previously that an alternate MS risk allele(s) may be encompassed by the telomerically extended DRB1*15 haplotype, and here, we have attempted to map the putative variant. Thirteen microsatellite markers encompassing a 6.79-megabase (D6S2236-G51152) region, and the DRB1 and DQB1 genes, were genotyped in 166 MS simplex families and 104 control families from the Australian State of Tasmania and 153 narcolepsy simplex families (trios) from the USA. Complementary approaches were used to investigate residual predisposing effects of microsatellite alleles comprising the extended DRB1*15 haplotype taking into account the strong predisposing effect of DRB1*15: (1) Disease association of the extended DRB1*15 haplotype was compared for MS and narcolepsy families--predisposing effects were observed for extended class I microsatellite marker alleles in MS families, but not narcolepsy families; (2) disease association of the extended DRB1*15 haplotype was investigated after conditioning MS and control haplotypes on the absence of DRB1*15--a significant predisposing effect was observed for a 627-kb haplotype (D6S258 allele 8-MOGCA allele 4; MOG, myelin oligodendrocyte glycoprotein) spanning the extended class I region. MOGCA allele 4 displayed the strongest predisposing effect in DRB1*15-conditioned haplotypes (p = 0.0006; OR 2.83 [1.54-5.19]). Together, these data confirm that an alternate MS risk locus exists in the extended class I region in Tasmanian MS patients independent of DRB1*15.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17256150     DOI: 10.1007/s00251-006-0183-5

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  34 in total

1.  Identifying nineteenth century genealogical links from genotypes.

Authors:  Jim Stankovich; Melanie Bahlo; Justin P Rubio; Christopher R Wilkinson; Russell Thomson; Annette Banks; Maree Ring; Simon J Foote; Terence P Speed
Journal:  Hum Genet       Date:  2005-05-10       Impact factor: 4.132

2.  On the utility of data from the International HapMap Project for Australian association studies.

Authors:  Jim Stankovich; Charles J Cox; Rachel B Tan; Douglas S Montgomery; Stewart J Huxtable; Justin P Rubio; Margaret G Ehm; Laura Johnson; Helmut Butzkueven; Trevor J Kilpatrick; Terence P Speed; Allen D Roses; Melanie Bahlo; Simon J Foote
Journal:  Hum Genet       Date:  2006-01-11       Impact factor: 4.132

Review 3.  Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives.

Authors:  S Overeem; E Mignot; J G van Dijk; G J Lammers
Journal:  J Clin Neurophysiol       Date:  2001-03       Impact factor: 2.177

4.  Polymorphism, recombination, and linkage disequilibrium within the HLA class II region.

Authors:  A B Begovich; G R McClure; V C Suraj; R C Helmuth; N Fildes; T L Bugawan; H A Erlich; W Klitz
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

5.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

6.  HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy.

Authors:  M C Ellis; A H Hetisimer; D A Ruddy; S L Hansen; G S Kronmal; E McClelland; L Quintana; D T Drayna; M S Aldrich; E Mignot
Journal:  Immunogenetics       Date:  1997       Impact factor: 2.846

7.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci.

Authors:  P C Sham; D Curtis
Journal:  Ann Hum Genet       Date:  1995-01       Impact factor: 1.670

8.  Polymorphisms of the tumor necrosis factor receptors: no association with narcolepsy in German patients.

Authors:  Stefan Wieczorek; Norbert Dahmen; Peter Jagiello; Joerg T Epplen; Martin Gencik
Journal:  J Mol Med (Berl)       Date:  2003-02-11       Impact factor: 4.599

9.  Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.

Authors:  Jorge R Oksenberg; Lisa F Barcellos; Bruce A C Cree; Sergio E Baranzini; Teodorica L Bugawan; Omar Khan; Robin R Lincoln; Amy Swerdlin; Emmanuel Mignot; Ling Lin; Douglas Goodin; Henry A Erlich; Silke Schmidt; Glenys Thomson; David E Reich; Margaret A Pericak-Vance; Jonathan L Haines; Stephen L Hauser
Journal:  Am J Hum Genet       Date:  2003-12-10       Impact factor: 11.025

10.  Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.

Authors:  J Hillert; O Olerup
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

View more
  5 in total

Review 1.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

Review 2.  Multiple Sclerosis and T Lymphocytes: An Entangled Story.

Authors:  Laurine Legroux; Nathalie Arbour
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-07       Impact factor: 4.147

Review 3.  Sleep disorders in multiple sclerosis. Review.

Authors:  Christian Veauthier
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

Review 4.  Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.

Authors:  Lennart T Mars; Philippe Saikali; Roland S Liblau; Nathalie Arbour
Journal:  Biochim Biophys Acta       Date:  2010-07-15

5.  Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population.

Authors:  Maria Giovanna Marrosu; Raffaele Murru; Gianna Costa; Maria Cristina Melis; Marcella Rolesu; Lucia Schirru; Elisabetta Solla; Stefania Cuccu; Maria Antonietta Secci; Michael B Whalen; Eleonora Cocco; Maura Pugliatti; Stefano Sotgiu; Giulio Rosati; Francesco Cucca
Journal:  BMC Genet       Date:  2007-05-17       Impact factor: 2.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.